Menu

CME Corner

Active Programs

Exploring the Role of Type 2 Inflammation in Uncontrolled Asthma

This interactive case-based activity will examine uncontrolled asthma and the role played by type 2 inflammation. ...

  • Mobile + Online on RealCME Mobile + Online on RealCME
  • ACCME

Managing Type 2 Diabetes: The Role of Insulin

Type 2 diabetes (T2D) is a chronic, highly prevalent disease. Despite the availability of many treatment options, including new insulin formulations that have the potential to simplify treatment regimens, improve treatment adherence, and provide clinical benefit, patients often have poor glycemic control. This activity will examine the role of insulin therapy in the management of T2D. ...

  • Online Presentation Online Presentation
  • ACCME
  • ACPE

The Value of Biosimilars in the Treatment of Inflammatory Bowel Disease

A number of biosimilars have been approved in recent years, offering additional treatment options for patients with IBD. Given the novelty of biosimilars in the U.S., it’s not surprising that clinicians have questions. In this activity, faculty will define biosimilars, examine how they’re studied and regulated, and discuss their current and potential role in IBD management, including how they migh ...

  • Video Roundtable Video Roundtable
  • ACCME

Expired Programs

Dialogue with the Experts: Diagnosing, Assessing, and Managing Inflammatory Rheumatic Diseases

Inflammatory rheumatic diseases, including rheumatoid arthritis (RA), psoriatic arthritis (PsA), and ankylosing spondylitis (AS), have a significant negative impact on patients’ physical functioning and quality of life. This activity will examine early recognition and guideline-driven treatment for these conditions. ...

  • Video Roundtable Video Roundtable
  • ACCME

Dialogue with the Experts: Strategies for Improving Interstitial Lung Disease Diagnosis and Treatment

An early and accurate diagnosis of ILD and its specific type is vital to directing therapy and monitoring disease course and therapeutic response, but these conditions are often mischaracterized and a correct diagnosis is very often delayed. This activity will examine recent advances in ILD diagnosis and treatment. ...

  • Video Roundtable Video Roundtable
  • ACCME

Early Collaboration in the Treatment of PsA: Examining the Crucial Coalition Between Dermatology and Rheumatology in Psoriatic Arthritis Treatment

Psoriatic arthritis (PsA) is a serious, inflammatory arthritis associated with psoriasis and multiple comorbidities that often goes undiagnosed and untreated. This activity will examine strategies for early recognition and referral, as well as specialty collaboration in the treatment of PsA. ...

  • i-Newsletter i-Newsletter
  • ACCME

Effective Strategies for Improving Process of Care Measures for Patients with IBD: Key Findings from a Community-Based QI Pilot

This activity will examine key findings from a quality improvement pilot designed to learn how IBD nurses in the community can proactively improve the care of patients with IBD. ...

  • Video Roundtable Video Roundtable
  • ANCC

Evolving Paradigms for Insulin Therapy of Type 2 Diabetes
Case Challenges in the Use of Insulin in T2DM (Activity 2 of 3)

This activity uses interactive case scenarios to examine challenges in the management of T2DM. ...

  • Mobile + Online on RealCME Mobile + Online on RealCME
  • ACCME

Evolving Paradigms for Insulin Therapy of Type 2 Diabetes
Management of T2DM: The Role of Insulin (Activity 1 of 3)

This activity examines challenges encountered in the management of T2DM and the many therapeutic options available to clinicians. ...

  • Mobile + Online on RealCME Mobile + Online on RealCME
  • ACCME

Identifying and Managing Patients with IBD at Risk for Progressive Disease

Treatment strategies for IBD vary depending on disease type, severity, and patient risk profile. This activity will examine severity and risk assessment, guideline recommended treatment, and patient communication strategies. ...

  • Online Presentation Online Presentation
  • ACCME

Improving Outcomes in Advanced Gastric Cancer: The Latest Updates in Treatment Strategies and Clinical Research

An estimated 26,370 Americans will be diagnosed with gastric cancer in 2016. Most patients with gastric cancer present with advanced or metastatic disease, for which the prognosis is poor. The 5-year survival rate of patients with all stages of gastric cancer in the United States is approximately 29% and drops into the single digits for patients with stage III or IV disease. However, recent advanc ...

  • Mobile + Online on Univadis Mobile + Online on Univadis
  • ACCME

Improving Outcomes in Patients with Heart Failure: Closing the Gaps

In the United States, heart failure (HF) affects about 5.7 million adults, accounts for >1 million hospitalizations annually, and is the leading cause of hospitalization for adults >65 years of age. Despite diagnostic and therapeutic advances in the last several decades and improved survival rates, roughly 50% of people with HF die within 5 years of diagnosis. Rates of cardiovascular death or HF-r ...

  • Online Presentation Online Presentation
  • ACCME

Improving the Management of Depression in Primary Care: Insights into Diagnosis and Treatment (Program ID 16052200)

Major depressive disorder (MDD) is one of the most common mental disorders diagnosed in the United States, with an estimated 16% of US adults experiencing MDD at some point during their lifetimes. According to the American Medical Association, chronic depression is often untreated and, on average, patients with depression receive the recommended quality of care only 58% of the time. The goal of th ...

  • Online Presentation Online Presentation
  • AANP

Multidisciplinary Care of Patients with Relapsed/Refractory Multiple Myeloma

The treatment landscape for multiple myeloma (MM) is rapidly evolving. This activity will examine tailored treatment approaches for patients with relapsed/refractory multiple myeloma. ...

  • Online Presentation Online Presentation
  • ACCME

netStride Test: Improving Outcomes in Patients with Heart Failure: Closing the Gaps

netStride Test: netStride Test: In the United States, heart failure (HF) affects about 5.7 million adults, accounts for >1 million hospitalizations annually, and is the leading cause of hospitalization for adults >65 years of age. Despite diagnostic and therapeutic advances in the last several decades and improved survival rates, roughly 50% of people with HF die within 5 years of diagnosis. Rates ...

  • Online Presentation Online Presentation
  • AAFP

Patient-Centered Care in Advanced Prostate Cancer

Recommended treatment options for prostate cancer vary based on disease severity and life expectancy, with traditional approaches including active surveillance, surgery, radiation therapy, chemotherapy, and androgen deprivation therapy (ADT). Prostate cancer that progresses despite ADT is known as castration-resistant prostate cancer (CRPC). Until recently, the standard of care for CRPC patients w ...

  • Mobile + Online on Univadis Mobile + Online on Univadis
  • ACCME

Primary Care Perspectives: Recognizing and Managing Opioid-Induced Constipation

Constipation is a common adverse effect resulting from opioid medications: an estimated 40% of patients receiving opioids to manage noncancer pain experience opioid-induced constipation (OIC). Unlike other adverse effects of opioids, such as nausea, the severity of OIC rarely diminishes over time and is often dose limiting. As a result, OIC can have a significant negative impact on activities of d ...

  • Mobile + Online on Univadis Mobile + Online on Univadis
  • ACCME

Psoriatic Arthritis: Understanding the Patient Experience to Improve Patient Satisfaction and Outcomes

The validated tools to assess PsA severity often do not capture what patients consider to be most important/challenging about their disease. To effectively engage patients when developing treatment plans, clinicians need information about the patients’ individual experiences with, perceptions of, and beliefs about PsA. In this “Rate the Quality” activity, you will meet three patients and rate the ...

  • Mobile + Online on RealCME Mobile + Online on RealCME
  • ACCME

Stroke Prevention in Atrial Fibrillation: Current Evidence for Tailoring Antithrombotic Therapy (Program ID: 15111981)

Nonvalvular atrial fibrillation (AF) is the most common sustained cardiac arrhythmia encountered in clinical practice and afflicts more than 3 million people in the United States. AF is an independent risk factor for ischemic stroke severity, recurrence, and mortality. Individuals with AF have a 4 to 5 times greater risk for ischemic stroke. The National Stroke Association emphasizes the importanc ...

  • Online Presentation Online Presentation
  • AANP

The Evolving Migraine Paradigm: Improving Diagnostic Accuracy

Migraine is underdiagnosed, frequently misdiagnosed, undertreated, and/or improperly managed, leading to reduced health-related quality of life, increased risk of psychiatric and medical comorbidities, and increased headache-related burden. This activity will improve clinicians' ability to diagnose migraine, resulting in improved outcomes for patients. ...

  • Mobile + Online on Univadis Mobile + Online on Univadis
  • ACCME

The Evolving Migraine Paradigm: Tailoring Treatment

Migraine is underdiagnosed and frequently misdiagnosed, undertreated, and/or improperly managed, leading to reduced health-related quality of life, increased risk of psychiatric and medical comorbidities, and increased headache-related burden. This activity will improve clinicians' ability to manage migraine in adult patients, resulting in improved outcomes for patients. ...

  • Mobile + Online on Univadis Mobile + Online on Univadis
  • ACCME

The Importance of Continued Co-management in the Treatment of PsA: Examining the Crucial Coalition Between Dermatology and Rheumatology in Psoriatic Arthritis Treatment

Psoriatic arthritis (PsA) is a serious, inflammatory arthritis associated with psoriasis and multiple comorbidities that often requires collaborative care between dermatologists, rheumatologists, and primary care clinicians. This activity will examine specialty collaboration and guideline recommended treatment. ...

  • i-Newsletter i-Newsletter
  • ACCME

Updates on Molecular Testing in NSCLC

Oncologists have new options when treating advanced NSCLC. The use of molecular profiling to define subgroups of patients most likely to experience clinical benefit from novel targeted therapies has been endorsed by both ASCO and the National Comprehensive Cancer Network (NCCN).This activity will examine the role of molecular biomarkers in patients with advanced NSCLC. ...

  • Mobile + Online on Univadis
  • ACCME
Main Menu
EDITOR'S PICKS